Target intelligence / Profile preview

Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1)

Target
SVEP1
Molecular classification
Secreted glycoprotein, Extracellular matrix protein, Ligand (for PEAR1 receptor), Other
01

Overview

Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1) is a large secreted extracellular matrix glycoprotein, characterized by the presence of sushi, von Willebrand factor type A, EGF-like, and pentraxin domains[1][3]. SVEP1 functions as a physiological ligand for the orphan receptor PEAR1, triggering downstream AKT/mTOR signaling that regulates platelet activation and influences vascular cell function[2]. It plays critical roles in cell adhesion, endothelial development, vascular homeostasis, and the regulation of vasoconstriction through integrin interactions[3]. Genetic variants and circulating levels of SVEP1 are associated with increased risk of atherosclerosis, coronary artery disease, hypertension, type 2 diabetes, and other aging-related diseases[2]. SVEP1 is under investigation as a potential biomarker and as a target for novel therapies to address vascular and thrombotic diseases, though no approved drugs directly target it to date[2].

Other names
POLYDOMC9orf13CCP22SELOBSEL-OBCCP module-containing protein 22Selectin-like osteoblast-derived proteinSelectin-like proteinSerologically defined breast cancer antigen NY-BR-38Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
02

Mechanism of action

Ligand for the Platelet and Endothelial Aggregation Receptor 1 (PEAR1); binding promotes PEAR1 phosphorylation, leading to AKT/mTOR signaling activation in vascular cells and platelets, promoting platelet activation and vascular remodeling[2].

03

Biological functions

Cell adhesionPlatelet activationRegulation of vasoconstrictionMorphological development of lymphatic endothelial cellsCell alignment and migration during embryonic developmentInhibition of vascular smooth muscle cell contraction (via integrins)Epidermal development and keratinocyte differentiation
04

Disease associations

Cardiovascular disease (including atherosclerosis, coronary artery disease, hypertension, heart failure, pulmonary artery hypertension)Type 2 diabetesThrombotic diseaseDementiaSepsis-related outcomesCancer (notably as a serologically defined breast marker)Glaucoma
05

Safety considerations

Since SVEP1 is broadly expressed and involved in developmental and vascular processes, targeting this pathway may carry risks such as impaired vascular development or platelet dysfunction (theoretical concerns based on functional roles rather than clinical evidence)[2].
06

Interacting drugs

None clinically established or approved. Experimental interest in targeting the SVEP1-PEAR1 interaction for *potential* therapeutic development in cardiovascular and thrombotic diseases has been proposed, but no specific drugs are named in available literature[2].
07

Biomarkers

SVEP1 plasma levels are explored as biomarkers for risk assessment in cardiovascular disease, diabetes, dementia, and related traits[2].

Beyond the preview

Go deeper on Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (SVEP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call